2-{3-[Hydroxy(Phenyl)Methyl]Phenyl}Propanoic Acid

2-{3-[Hydroxy(Phenyl)Methyl]Phenyl}Propanoic Acid

SCHEMBL4380095

CC(C(=O)O)c1cccc(C(O)c2ccccc2)c1

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 6/20 0.62
PTGS2 P35354 6/20 0.62
LMNA P02545 4/20 0.62
MAPT P10636 3/20 0.62
CXCR1 P25024 2/20 0.62
CXCR2 P25025 2/20 0.62
SMN1; SMN2 Q16637 2/20 0.62
HPGD P15428 2/20 0.62
SLC22A6 Q4U2R8 2/20 0.62
HIF1A Q16665 2/20 0.62
MAPK1 P28482 2/20 0.62
RECQL P46063 1/20 0.62
KDM4E B2RXH2 1/20 0.62
ALDH1A1 P00352 1/20 0.62
CYP3A4 P08684 1/20 0.62
PMP22 Q01453 1/20 0.62
HSD17B10 Q99714 1/20 0.62
CXCL8 P10145 1/20 0.62
THPO P40225 1/20 0.62
MEN1 O00255 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
2-{3-[Hydroxy(Phenyl)Methyl]Phenyl}Propanoic Acid SCHEMBL8851022 1.00 PTGS1 (0.62) PTGS1PTGS2LMNAMAPTCXCR1
2-{3-[Hydroxy(Phenyl)Methyl]Phenyl}Propanoic Acid SCHEMBL12129512 1.00 PTGS1 (0.62) PTGS1PTGS2LMNAMAPTCXCR1
2-{3-[Hydroxy(Phenyl)Methyl]Phenyl}Propanoic Acid SCHEMBL8851028 1.00 PTGS1 (0.62) PTGS1PTGS2LMNAMAPTCXCR1
SCHEMBL602096 0.88 PTGS2 (0.69) PTGS1PTGS2LMNAMAPTCXCR1
SCHEMBL1344829 0.85 PTGS1 (0.61) PTGS1PTGS2LMNAMAPTCXCR1
SCHEMBL1345442 0.85 PTGS1 (0.61) PTGS1PTGS2LMNAMAPTCXCR1
SCHEMBL1345440 0.85 PTGS1 (0.61) PTGS1PTGS2LMNAMAPTCXCR1
SCHEMBL12018881 0.83 PTGS1 (0.64) PTGS1PTGS2LMNAMAPTCXCR1
SCHEMBL3630168 0.83 PTGS1 (0.64) PTGS1PTGS2LMNAMAPTCXCR1
SCHEMBL3147627 0.83 PTGS1 (0.64) PTGS1PTGS2LMNAMAPTCXCR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1255726-B1 (R)-2-ARYL-PROPIONAMIDES, USEFUL IN THE INHIBITION OF IL-8 INDUCED CHEMIOTAXIS OF NEUTROPHILS DOMPE PHA R MA SPA RES & MFG (IT) 2009-11-11 EP disclosed
US-20040181073-A1 Amides, useful in the inhibition of il-8-induced chemotaxis of neutrophils DOMPÉ FARMACEUTICI S.P.A. (IT) 2004-09-16 US disclosed
EP-0529444-B1 2-Arylpropenic acids and their utilisation in the preparation of 5-ketoprofen BAYER AG (DE) 1997-04-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040181073-A1 Amides, useful in the inhibition of il-8-induced chemotaxis of neutrophils CXCL8, MMP8, CCR8 PTGS1 171/4885PTGS2 219/4885LMNA 3228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.